Yale study pulmonary embolism treatment widely used despite high cost and uncertain benefit

Despite being costly and of little Known benefit, a Process of Treating pulmonary embolism with blood clot blockers is routinely utilized in elderly adults, Yale School of Medicine researchers and their colleagues present at a new analysis. The analysis also revealed that the usage levels of inferior vena caval (IVC) filters varied widely across different regions inside the USA. IVC filters have been targeted at blocking the course of blood clots to stop pulmonary embolism, a condition where oxygen or blood clots obstruct blood circulation in blood vessels. “The best utilization of this IVC filter Technology remains unclear, yet this action with very narrow signs is being conducted at any in six patients,” explained Bikdeli. “Further research helps identify the sub groups of people who may benefit from this process”

Directed by Dr. Behnood The researchers found frequent and rising usage of IVC filters in patients having pulmonary embolism as time passes, whilst death from pulmonary embolism decreased during precisely the exact same period of time, irrespective of if IVC filters were used. Additionally they discovered that outside from those 550,000 elderly adults having pulmonary embolism, over 15 percent (94,000) received an IVC filter. Bikdeli explained that IVC filters may be acceptable for a selection of patients, however, maybe not for such wide spread usage. “Unlike To a shared beliefs, they have been just not really a bullet proof vest contrary to pulmonary embolism,” he explained. “considering the fact this procedure isn’t devoid of complications or costs, we absolutely require good relative effectiveness studies to ascertain which patients can take advantage of IVC filters” Additional Samuel Goldhaber, also Harlan Krumholz.


Our most popular topics on Managedcaremag.com